Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

C-Path Partners with CHDR to Expand Global Collaborations

The Critical Path Institute and the Centre for Human Drug Research (CHDR) have joined forces to expand global collaborations for b

Safety biomarkers aim to provide an additional tool for detecting acute drug-induced skeletal muscle injury in phase 1 clinical tr

Biomarker aims to provide an additional tool for detecting the onset of hepatic injury in clinical trials involving patients with

TUCSON, Ariz., July 14, 2020 — Tucson-based Critical Path Institute (C-Path) today proudly announced that the analytics team f

June 24, 2020

Clinicians to report novel uses of existing drugs through FDA-NCATS CURE ID Mobile App. TUCSON, Ariz., June 23, 2020 — As millio

June 19, 2020

June 20, 2020

Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplan

June 24, 2020

Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera

June 14, 2020